2.36
price down icon5.98%   -0.15
after-market Handel nachbörslich: 2.36
loading
Schlusskurs vom Vortag:
$2.51
Offen:
$2.55
24-Stunden-Volumen:
185.78K
Relative Volume:
0.93
Marktkapitalisierung:
$21.19M
Einnahmen:
$93.76M
Nettoeinkommen (Verlust:
$-13.68M
KGV:
-0.8973
EPS:
-2.63
Netto-Cashflow:
$8.77M
1W Leistung:
+24.21%
1M Leistung:
+3.51%
6M Leistung:
+131.37%
1J Leistung:
+5.36%
1-Tages-Spanne:
Value
$2.35
$2.59
1-Wochen-Bereich:
Value
$1.96
$2.59
52-Wochen-Spanne:
Value
$0.95
$2.82

Aytu Biopharma Inc Stock (AYTU) Company Profile

Name
Firmenname
Aytu Biopharma Inc
Name
Telefon
(720) 437-6580
Name
Adresse
7900 E. UNION AVENUE, DENVER
Name
Mitarbeiter
83
Name
Twitter
@aytubioscience
Name
Nächster Verdiensttermin
2024-12-13
Name
Neueste SEC-Einreichungen
Name
AYTU's Discussions on Twitter

Vergleichen Sie AYTU mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AYTU
Aytu Biopharma Inc
2.36 24.88M 93.76M -13.68M 8.77M -2.63
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-01 Eingeleitet Lake Street Buy
2025-06-30 Eingeleitet Ascendiant Capital Markets Buy
2021-03-30 Eingeleitet Cantor Fitzgerald Overweight
2020-05-29 Eingeleitet H.C. Wainwright Buy

Aytu Biopharma Inc Aktie (AYTU) Neueste Nachrichten

pulisher
Oct 10, 2025

What earnings revisions data tells us about Aytu BioPharma Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using data models to predict Aytu BioPharma Inc. stock movementMarket Weekly Review & Low Volatility Stock Suggestions - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Aytu BioPharma to Present at Upcoming October 2025 Conferences - ACCESS Newswire

Oct 10, 2025
pulisher
Oct 10, 2025

How to use Fibonacci retracement on Aytu BioPharma Inc.Analyst Upgrade & Community Supported Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why institutional investors increase stakes in Aytu BioPharma Inc. (AY20) stockAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How institutional ownership impacts Aytu BioPharma Inc. stockWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Aytu BioPharma Inc AY20 Stock Analysis and ForecastMomentum Trading Signals & Free Double Digit Growth Tips - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

What analysts say about Aytu BioPharma Inc stockTake Profit Strategies & Fast Profit Trading Tips - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Is Aytu BioPharma Inc. (AY20) stock attractive for growth fundsJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsEarnings Growth Report & Entry Point Strategy Guides - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Aytu BioPharma Reports Fiscal 2025 Earnings and EXXUA Launch Plans - MSN

Oct 04, 2025
pulisher
Oct 04, 2025

Will Rising Interest Rates Hurt Lupin Limited’s Profit MarginsMarket Correction Analysis & Set Up Real-Time Alerts – It’s Free - earlytimes.in

Oct 04, 2025
pulisher
Oct 03, 2025

Aytu BioPharma Inc. stock momentum explainedJuly 2025 Snapshot & High Accuracy Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Applying sector rotation models to Aytu BioPharma Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio - MSN

Oct 02, 2025
pulisher
Oct 02, 2025

Is It Time to Lock in Profits on Mefcom Capital Markets Limited StockValue Stock Picks & Minimal Investment Capital Gains - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

What drives Aytu BioPharma Inc AY20 stock priceInterest Rate Changes & Minimal Risk High Reward - earlytimes.in

Oct 02, 2025
pulisher
Sep 30, 2025

Aytu BioPharma at Lytham Partners: Strategic Realignment and Growth By Investing.com - Investing.com Canada

Sep 30, 2025
pulisher
Sep 27, 2025

Aytu BioPharma (NASDAQ:AYTU) Downgraded by Wall Street Zen to “Hold” - Defense World

Sep 27, 2025
pulisher
Sep 27, 2025

Aytu BioPharma (NASDAQ:AYTU) Given New $12.50 Price Target at Ascendiant Capital Markets - Defense World

Sep 27, 2025
pulisher
Sep 25, 2025

Ascendiant Capital Maintains Aytu BioPharma (AYTU) Buy Recommendation - Nasdaq

Sep 25, 2025
pulisher
Sep 25, 2025

Maxim Group Maintains Aytu BioPharma (AYTU) Buy Recommendation - Nasdaq

Sep 25, 2025

Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aytu Biopharma Inc-Aktie (AYTU) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Disbrow Joshua R.
Chief Executive Officer
Jun 09 '25
Buy
1.50
66,666
99,999
153,257
Disbrow Joshua R.
Chief Executive Officer
Feb 28 '25
Buy
1.30
15,000
19,500
86,591
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):